Accumulating evidence suggests that Wnt signaling and KRAS mutations induce metabolic reprogramming in the adenoma and carcinoma stage of CRC to support the energetic and biosynthetic requirements of rapidly proliferating CRC cells. The gene discussed is KRAS; the disease is colorectal carcinoma.